INmune Bio
$2.809876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.18 (+6.62%) Today
-$0.10 (-3.45%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell INmune Bio and other stocks, options, ETFs, and crypto commission-free!
About INMB
INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer's disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE. Read More The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.
Employees
4
Headquarters
La Jolla, California
Founded
2015
Market Cap
31.17M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
24.28K
High Today
$3.31
Low Today
$2.51
Open Price
$2.83
Volume
21.74K
52 Week High
$11.50
52 Week Low
$2.20
Collections
INMB Earnings
-$0.28
-$0.19
-$0.09
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 13, Pre-Market